Simple Summary Through implementation of HPV testing as standard primary screening
method, the number of women diagnosed with high-grade cervical intraepithelial neoplasia …

High-grade cervical intraepithelial neoplasia (CIN2 and CIN3) represents a heterogeneous
disease with varying cancer progression risks. Biomarkers indicative for a productive human …

Background. Cervical cancer (CC) is a major malignancy affecting women worldwide, with
limited treatment options for patients with advanced disease. The aim of this study was to …

Recent genome-wide association studies (GWASs) in subjects of European descent have
identified associations between cervical cancer risk and three independent loci as well as …

Objective This study aimed at evaluating whether human papillomavirus (HPV) groups and
E6/E7 mRNA of HPV 16, 18, 31, 33, and 45 are prognostic of cervical intraepithelial …

Objective: Cervical cancer is one of the most common gynecological malignancies. The
interaction between tumor microenvironment and immune infiltration is closely related to the …

Introduction Cervical intraepithelial neoplasia grade 2 (CIN2) represents a spectrum of
lesions with variable progression and regression. Pathological diagnosis of CIN2 is …

Background There is no prognostic test to ascertain whether cervical intraepithelial
neoplasias (CINs) regress or progress. The majority of CINs regress in young women, and …

Objective. A pilot study to determine genomic microarray differences in patients with normal
cervical tissue and cervical intraepithelial neoplasia (CIN) 3. Materials and Methods. After …

Background Cervical cancer is frequently detected gynecological cancer all over the world.
This study was designed to develop a prognostic signature for an effective prediction of …